Gritstone Asset Management’s Biotech Acquisition Company Class A Ordinary Shares BIOT Stock Holding History

Gritstone Asset Management’s Portfolio BIOT Stock Details BIOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-39,247	Closed	-$396K	–	235
2022 Q4	$396K	Buy	+39,247	New	+$393K	0.5%	69

Gritstone Asset Management's BIOT Position: Q1 2023 in Review

Gritstone Asset Management sold out of Biotech Acquisition Company Class A Ordinary Shares (BIOT) in Q1 2023, closing a stake of 39,247 shares — an estimated $396K sold.

Gritstone Asset Management first reported a position in BIOT in Q4 2022 and held it in 1 quarter. The position peaked at $396K in Q4 2022. 0 funds tracked by Wall St. Rank hold BIOT as of Q1 2023.

Gritstone Asset Management reported no remaining Biotech Acquisition Company Class A Ordinary Shares position as of Q1 2023 after selling out during the quarter.
Gritstone Asset Management sold 39,247 Biotech Acquisition Company Class A Ordinary Shares shares in Q1 2023, an estimated $396K.
Gritstone Asset Management first reported a position in Biotech Acquisition Company Class A Ordinary Shares in Q4 2022 and held it in 1 quarter.
Gritstone Asset Management's Biotech Acquisition Company Class A Ordinary Shares position peaked at $396K in Q4 2022.
0 funds tracked by Wall St. Rank held Biotech Acquisition Company Class A Ordinary Shares as of Q1 2023.

Based on Gritstone Asset Management's 13F filing for Q1 2023, filed 5 May 2023.